Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy
- 1 April 1992
- journal article
- case report
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (4), 344-348
- https://doi.org/10.1111/j.1471-0528.1992.tb13737.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists?Journal of Clinical Endocrinology & Metabolism, 1990
- A Risk-Benefit Assessment of Estrogen Therapy in Postmenopausal WomenDrug Safety, 1990
- Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative studyFertility and Sterility, 1989
- 9 LHRH analogues: their clinical physiology and delivery systemsBailliere's Clinical Obstetrics and Gynaecology, 1988
- 10 LHRH analogues in the treatment of endometriosis—comparative results with other treatmentsBailliere's Clinical Obstetrics and Gynaecology, 1988
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonistFertility and Sterility, 1982
- Interim report of a study of danazol for the treatment of endometriosisFertility and Sterility, 1982